Fact of Medicine

  • Brand Name: Aliqopa
  • Innovator Brand Name: Aliqopa
  • API: Copanlisib
  • Packaging: 1 Vial (Per Box)
  • Strength: 60mg
  • Manufacturer Name: Bayer Corporation
Get Price


Uses of medication: Aliqopa (Copanlisib) is used in order to treat adult patients with relapsed follicular lymphoma (FL) who have received at least 2-prior systemic therapies.

Dosage: The recommended aliqopa 60 mg dose should be administered as a 1-hour intravenous infusion on Days 1, 8, and 15 of a 28-day treatment cycle on an intermittent schedule (3-weeks on and 1-week off). Treatment with aliqopa should be continued until the disease progression or not acceptable toxicity.

Treatment Reactions: The most commonly reported aliqopa side effects include:

  • Hyperglycemia
  • Diarrhea
  • Hypertension
  • Leukopenia
  • Neutropenia
  • Nausea
  • Lower respiratory tract infections
  • Thrombocytopenia
  • Decreased general strength and energy

Warnings and Precautions:

  • Diabetes mellitus patients should only be treated with aliqopa 60 mg after adequate glucose control and should be monitored closely.
  • Pre- and post-infusion of copanlisib, patients should be monitored for BP.
  • While on treatment with copanlisib 60 mg patients should be monitored for blood counts at least weekly basis.
  • Do not administer copanlisib during pregnancy, as this medication can be responsible for causing fetal harm if administered to a pregnant woman.
  • Lactating women should not breastfeed during treatment with copanlisib 60 mg and for at least 30 days following the final dose.
  • Patients with aliqopa should be monitored for signs and symptoms of infection. Withhold the treatment for Grade-3 and higher infections until the resolution.

More Info

Storage: Vials of aliqopa should be refrigerated at 2°C to 8°C (36°F to 46°F). Avoid exposure of the diluted solution to the direct sunlight.

Availability in India: The Indian Pharma (TIP) helps connect buyers with suppliers who can ship ALIQOPA at the global level as per the need of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the ALIQOPA Injections.

Buying Procedure: In order to buy ALIQOPA, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp number +919310090915 or an Email to us at: along with your ID Proof, Valid Prescription Letter and Medical Reports.

Conclusion: Since the aliqopa fda approval, this treatment provides an alternative option for patients with relapsed follicular lymphoma. This agent is safe as well as effective and demonstrates an acceptable toxicity profile.

commonly asked questions

What does Aliqopa contain as an active substance?

The medication Aliqopa specifically contains the active substance Copanlisib.

From which class of drug Copanlisib belongs?

Copanlisib basically belongs to a class of drugs named kinase inhibitors. (PI3K or phosphatidylinositol-3-kinase inhibitor).

How does Copanlisib act?

As a kinase inhibitor (PI3K), Copanlisib acts in order to block the numerous existing enzymes that are involved in promoting the growth of cancer cells.

How much does aliqopa cost?

The aliqopa price in india may vary depending on the wholesaler/pharmacy you visit. The aliqopa price is around 358,344 INR for the supply of 1-powder for injection.

Where can I get Copanlisib at the best price?

In order to get the best copanlisib price, always buy this medication from a such Pharmaceutical Wholesaler Company which is ISO and WHO-GDP certified.

Can I get Copanlisib (Aliqopa) even if I am not based in India?

The Indian Pharma helps patients in accessing or importing Copanlisib (Aliqopa), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.